Literature DB >> 2023107

Evaluation of the utility of a proposed method for correcting for intrasubject variability in metabolic clearance in the bioavailability assessment of theophylline.

Y Kasuya1, T Furuta, H Shibasaki, H Shimota.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2023107     DOI： 10.1007/bf01062195

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN： 0090-466X


× No keyword cloud information.
  8 in total

1.  Intrapatient variability in theophylline kinetics.

Authors:  P D Walson; R C Strunk; L M Taussig
Journal:  J Pediatr       Date:  1977-08       Impact factor: 4.406

2.  Variation in theophylline clearance rate with time in chronic childhood asthma.

Authors:  P Leung; A Kalisker; T D Bell
Journal:  J Allergy Clin Immunol       Date:  1977-06       Impact factor: 10.793

3.  New method for bioavailability assessment of slow-release preparations of theophylline.

Authors:  Y Kasuya; T Ohno; N Kubota; H Takahashi; H Hirayama
Journal:  J Pharmacokinet Biopharm       Date:  1985-12

4.  Simultaneous determination of the intravenous and oral pharmacokinetic parameters of D,L-verapamil using stable isotope-labelled verapamil.

Authors:  M Eichelbaum; A Somogyi; G E von Unruh; H J Dengler
Journal:  Eur J Clin Pharmacol       Date:  1981-01       Impact factor: 2.953

5.  Capillary gas chromatographic-mass spectrometric determination of stable isotopically labelled and unlabelled theophylline in serum and urine and of 1,3-dimethyluric acid in urine.

Authors:  Y Kasuya; T Furuta; H Shimota
Journal:  J Chromatogr       Date:  1989-09-29

6.  Bioavailability of imipramine tablets relative to a stable isotope-labeled internal standard: increasing the power of bioavailability tests.

Authors:  H A Heck; S E Buttrill; N W Flynn; R L Dyer; M Anbar; T Cairns; S Dighe; B E Cabana
Journal:  J Pharmacokinet Biopharm       Date:  1979-06

7.  Bioavailability and kinetics of maprotiline.

Authors:  D Alkalay; W E Wagner; S Carlsen; L Khemani; J Volk; M F Bartlett; A LeSher
Journal:  Clin Pharmacol Ther       Date:  1980-05       Impact factor: 6.875

8.  Stable-isotope methodology in the bioavailability study of 17 alpha-methyltestosterone using gas chromatography-mass spectrometry.

Authors:  Y Shinohara; S Baba; Y Kasuya; G Knapp; F R Pelsor; V P Shah; I L Honigberg
Journal:  J Pharm Sci       Date:  1986-02       Impact factor: 3.534
  8 in total
  1 in total

1.  Pharmacokinetic analysis of mizolastine in healthy young volunteers after single oral and intravenous doses: noncompartmental approach and compartmental modeling.

Authors:  F Mesnil; C Dubruc; F Mentre; S Huet; A Mallet; J P Thenot
Journal:  J Pharmacokinet Biopharm       Date:  1997-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.